DROXIA 6335 DROXIA 6335 Pill - green capsule/oblong, 16mm
Generic Name: hydroxyurea
Pill with imprint DROXIA 6335 DROXIA 6335 is Green, Capsule/Oblong and has been identified as Droxia 200 mg. It is supplied by Bristol-Myers Squibb.
Droxia is used in the treatment of Sickle Cell Disease; Solid Tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DROXIA 6335 DROXIA 6335
Droxia
- Generic Name
- hydroxyurea
- Imprint
- DROXIA 6335 DROXIA 6335
- Strength
- 200 mg
- Color
- Green
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00003-6335
- Inactive Ingredients
-
citric acid monohydrate,
gelatin,
magnesium stearate,
sodium phosphate,
titanium dioxide,
FD&C Blue No. 1,
FD&C Green No. 3
Note: Inactive ingredients may vary.
More about Droxia (hydroxyurea)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
